MedPath

Efficacy of essential oil mouthwash in reducing antimicrobial load among head and neck cancer treated patients post-radiotherapy - A clinical trial

Phase 2
Conditions
Health Condition 1: C068- Malignant neoplasm of overlappingsites of other and unspecified parts of mouthHealth Condition 2: K137- Other and unspecified lesions of oral mucosa
Registration Number
CTRI/2022/08/044969
Lead Sponsor
Dr Mehul Ajit Shah
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients having histopathologically confirmed squamous cell carcinoma of head and neck region scheduled for 6ââ?¬â??7 weeks of RT with 60ââ?¬â??70Gy radiation dose (200cGy/ fraction for 5 days/week) irrespective of age and gender.

2.Patients with Karnofsky performance status score �70% (to assess the ability of the patients to follow instructions).

Exclusion Criteria

1. Physically handicapped/terminally ill patients which can affect the use of mouthwash.

2. Patients using any other mouthwash.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath